Worth reading
74In focus
Scored from 2 of 5 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.This transaction
株式会社ミルテルの株式取得（子会社化）Disclosing companyMedical Net,Inc.
The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.The percentage before the change is not stated in this document.
Execution Date / Effective Date2024年１月５日
Target company
Contract Clinical Testing
Location Minami-ku, Hiroshima, Hiroshima PrefectureShare capital 9,500万円Date of incorporation 3 September 2012
Procedures and assumptions
Management structure after acquisition代表取締役は加藤俊也。
| Item | Details |
|---|---|
| Transaction name | 株式会社ミルテルの株式取得（子会社化） |
| Name of the Subject Company | 株式会社ミルテル |
| Business Description of the Subject Company | Contract Clinical Testing |
| Location of the Subject Company | Minami-ku, Hiroshima, Hiroshima Prefecture |
| Capital Stock of the Subject Company | 9,500万円 |
| Date of Establishment of the Subject Company | 3 September 2012 |
| Voting rights ownership percentage | After 71.1％ (before not disclosed) |
| Execution Date / Effective Date | 2024年１月５日 |
| Management structure after acquisition | 代表取締役は加藤俊也。 |
Items this document does not state (25)
Counterparty nameNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodNumber of shares acquiredFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Impact on Business PerformanceDate of board resolutionContract DateValuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to ExecutionChange of corporate nameTreatment of employees
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.2023年11月27日付および2023年12月21日付の公表事項に沿って、株式会社ミルテルの株式取得が完了したため。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.